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Introduction: Acute upper gastrointestinal bleeding (AUGIB) is a common reason for admission to
gastroenterologists, with only 2% of patients requiring surgical intervention. The aim of this study was to
review the surgical management of patients with non-variceal AUGIB in a single institution over a 12-
year period and compare practice with recognised regional and national standards.
Materials and Methods: Data was collected retrospectively for all patients undergoing surgery for AUGIB
between September 1995 and September 2007. Audit standards included the local hospital protocol,
British Society of Gastroenterology Endoscopy Committee guidelines and the UK Comparative Audit of
AUGIB and the Use of Blood.
Results: 53 patients were identiﬁed, of which 41 case notes were available. Mean (range) age of the
patients was 75.8 (45e92) years. 56% had pre-existing cardiorespiratory comorbidity and 63% were
taking anti-inﬂammatory drugs. Pre-operative Rockall score was 7 in 46% and ASA score was 3 in 65%
of patients. 56% of operations were performed by the registrar, compared with 20% reported nationally.
All cases after 2004 were performed by the consultant. No operations were performed after midnight
beyond 1999. 23 (56%) patients suffered post-operative complications compared with 55% reported
nationally; cardiorespiratory (n ¼ 16), wound infection (n ¼ 7) and rebleed (n ¼ 6). 37% required
intensive care support and median length of hospital stay was 13 days. In-hospital mortality rate was
10%, compared with 30% reported nationally and this increased with rising Rockall, Blatchford, APACHE-
2, P-POSSUM and Charlson scores.
Conclusions: These ﬁndings highlight the high rate of morbidity and mortality associated with surgical
treatment for AUGIB. The small volume of cases and reduction in registrar operating raises training
issues. An integrated approach with greater use of interventional radiology is likely to play a greater role
in the future.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Acute upper gastrointestinal bleeding (AUGIB) is one of the com-
monest emergency admissions to gastroenterologists. It has an inci-
dence of 103e170 per 100,000 population each year,1,2 with
a reported mortality of 7e11% in patients admitted to hospital and
26e33% in those developing bleeding whilst an inpatient for other
reasons.3 In 2007 a UK comparative audit of AUGIB and the use of
bloodwasconducted, demonstrating that themajorityofpatients can
be managed successfully with endoscopic therapy. Surgery was
required in only 2% of patients, compared to 7% in 1993, with an
associatedmortality rate of 30% and complications occurring in 55%.3Tracey, Devon, TQ13 9YZ, UK.
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ciates Ltd. Published by Elsevier LtThe aim of this study was to review our 12-year experience of
surgical management of patients with AUGIB at a single institution
and identify potential areas for future improvement.2. Materials and methods
A retrospective review of case notes of all patients requiring
surgery for AUGIB between September 1995 and September 2007
was performed. Patients were identiﬁed from the Patient Admin-
istration System (PAS) and theatre computer records using the
diagnosis codes for ‘duodenal ulcer with haemorrhage’, ‘gastric
ulcer with haemorrhage’ and ‘gastrointestinal haemorrhage’, in
addition to operation codes for ‘operations on ulcer of duodenum’
and ‘operations on ulcer of stomach’. Information regarding patient
demographics, comorbidity, clinical examination ﬁndings, pre-
operative investigations, peri-operative details and post-operatived. All rights reserved.
Table 1
Audit standards and outcomes relating to surgical management of acute upper gastrointestinal bleeding.
Audit Criteria Exceptions Source of evidence Target Outcomes
Correct indications
for surgical referral
None Hospital protocol 100% 100%
Decision to operate/not
operate discussed with consultant
None Hospital protocol 100% 93%
BSG Guidelines
Timing of operation
(avoid 00:00e07:00 where feasible)
Haemodynamic
instability
BSG Guidelines 100% 80%
Consultant or appropriately
trained surgeon
None BSG Guidelines 100% 100%
In-hospital mortality rate None UK Audit 30% 10%
Complication rate None UK Audit 55% 56%
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Blatchford scores weremeasured,4,5 in addition to Acute Physiology
and Chronic Health Evaluation (APACHE) II score, Portsmouth
Physiologic and Operative Severity Score for the enUmeration of
Mortality and Morbidity (P-POSSUM) and Charlson scores.6e8
The audit criteria were deﬁned using three main data sources;
these included the local hospital protocol, British Society of
Gastroenterology (BSG) Endoscopy Committee guidelines9 and the
UK Comparative Audit of Upper Gastrointestinal Bleeding and the
Use of Blood.3 Comparison was made between these accepted
standards and our practice (Table 1).
3. Results
53 patients were identiﬁed of which only 41 patients’ notes
were available. The baseline characteristics for these patients are
displayed in Table 2. 70% of patients were aged >70 years with
a similar sex distribution.
3.1. Referral
17 patients were referred by their GP, 22 patients by the Acci-
dent & Emergency department, 1 from endoscopy and 1 from
a community hospital. 33 patients were primarily referred to
medicine and 8 patients to surgery. Those patients primarily
referred to medicine were subsequently referred to the surgical
team after a mean (range) of 1.5 (0e10) days.
3.2. Symptoms and signs
Patient symptoms included haematemesis (n ¼ 22), coffee
ground vomit (n ¼ 5), melaena (n ¼ 26), abdominal pain (n ¼ 2),
rectal bleeding (n¼ 1) and anaemia (n¼ 1). Rectal examinationwas
only performed in 23 (56%) patients, of which melaena was noted
in 15 patients.Table 2
Patient demographics.
Characteristics Value
Age Mean (yrs) 75.8
Range (yrs) 45e92
Sex Male 21 (51%)
Female 20 (49%)
Drug history NSAID 26 (63%)
Steroids 2 (5%)
PPI 3 (7%)
Warfarin 3 (7%)
Comorbidity Cardiac 21 (51%)
Respiratory 2 (5%)
Renal 2 (5%)
Peptic ulcer 6 (15%)
Neurological 9 (22%)
Endocrine 8 (20%)3.3. Endoscopy
98% (n¼ 40) of patients underwent endoscopy. 1 patient did not
undergo endoscopy and instead received immediate surgery due to
haemodynamic instability. Endoscopic ﬁndings included duodenal
ulcer (n¼ 28), gastric ulcer (n¼ 10) and dieulafoy lesion (n¼ 2). All
of these patients demonstrated stigmata of recent haemorrhage
(blood in upper GI tract, adherent clot, visible or spurting vessel).
Endoscopic therapy included injection sclerotherapy (n ¼ 32),
endoclips (n ¼ 4) and heater probe (n ¼ 2). Blatchford and pre-/
post-endoscopy Rockall scores are displayed in Table 3.
3.4. Surgical referral
According to the hospital protocol the surgical team must be
informed about all patients aged <60 years with a transfusion
requirement>8 units in 24 h, OR 2 re-bleeds (after best endoscopic
therapy), OR spurting vessel not controlled at endoscopy, OR
continued bleeding. Likewise patients aged 60 years with
a transfusion requirement >4 units in 24 h, OR one rebleed (after
best endoscopic therapy), OR spurting vessel not controlled at
endoscopy OR continued bleeding must be discussed. In the
present study all patients undergoing surgery had been referred
appropriately according to this deﬁned protocol, with ‘continued
bleeding despite endoscopy’ the commonest reason documented.
3.5. Peri-operative
Details relating to the operations performed are displayed in
Table 4. Discussionwith a consultant of the decision to operate was
documented in 93% (n ¼ 38) patients’ notes, with 7% (n ¼ 3)
patients having no such documentation. In each of these 3 cases, no
consultant was present at the operation. Whilst surgery was per-
formed by the registrar in 56% (n ¼ 23) of cases, all cases beyondTable 3
Pre- and post-endoscopy risk scores.
Scoring method Score Number of patients
(n ¼ 41)
Blatchford 0e5 1
6e10 9
11e15 26
16e23 5
Rockall (pre-endoscopy) 1 6
2 9
3 7
4 12
5 7
Rockall (post-endoscopy) 4 6
5 9
6 7
7 12
8 7
Table 4
Peri-operative details of all patients undergoing surgery.
Characteristic Number of
patients (n ¼ 41)
ASA 1 0 (0%)
2 14 (34%)
3 17 (41%)
4 10 (24%)
Timing of surgery Day (08:00e17:00) 17 (41%)
Evening (17:01e24:00) 16(39%)
Night (00:01e08:00) 8 (20%)
Lead surgeon Consultant 18 (44%)
Registrar 23 (56%)
Operation performed Simple underrun/excision 37 (90%)
Partial gastrectomy 4 (10%)
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surgery was performed during the hours of 00:00e07:00 in 20% of
cases, there were no cases performed during these hours after
1999. 40% (n ¼ 4) of patients with conﬁrmed gastric ulcer under-
went gastrectomy with simple underrun performed in the
remaining patients (n ¼ 6).
3.6. Post-operative
37% (n ¼ 15) patients required intensive care unit (ICU) support
following surgery, with a median (range) length of stay on ICU of 2
(1e24) days. Post-operatively 51% (n ¼ 21) patients were
commenced on oral triple therapy. Median (range) length of post-
operative stay was 13 (1e180) days.
Overall 56% (n ¼ 23) patients suffered post-operative compli-
cations. 15% (n ¼ 6) patients suffered a rebleed following surgery,
with 3 patients requiring further surgery and 3 requiring repeat
endoscopy on the same admission. 17% (n ¼ 7) patients suffered
wound complications, including wound dehiscence and wound
infection. 19% (n ¼ 8) patients suffered lower respiratory tract
infections and 19% (n ¼ 8) patients suffered cardiac complications
including atrial ﬁbrillation (n ¼ 6) and congestive cardiac failure
(n ¼ 2).
In-hospital mortality rate was equivalent to 30-day mortality at
10% (n ¼ 4). 80% (n ¼ 33) of patients were alive at more than 1 year
following surgery. There was 1 in-hospital death amongst 18
patients undergoing surgery by a consultant, compared with 3
deaths amongst 23 patients undergoing surgery by a registrar.
Further analysis of these in-hospital mortality rates relating to
recognised comorbidity scoring systems are outlined in Table 5.Table 5
Relationship between prognostic scoring system and in-hospital mortality rate.
Scoring system Score In-hospital
mortality (%)
Rockall (post-endoscopy) 0e4 0
5e7 11
8 29
Blatchford 0e9 0
10e14 8
15 22
ASA 2 14
3 6
4 10
Charlson 0 5
1e4 10
5 18
APACHE-2 0e10 0
>10 11
P-POSSUM (physiology score) 0e29 0
30e40 13
>40 174. Discussion
In the present study, surgery for non-variceal AUGIB was asso-
ciated with a high rate of post-operative morbidity and mortality,
the majority of patients being aged over 70 years with pre-existing
cardiorespiratory comorbidity. These ﬁndings are consistent with
those of the recent UK Comparative Audit of Upper Gastrointestinal
Bleeding, in which the median age of patients undergoing surgery
was 73 years, with a morbidity and mortality rate of 55% and 30%
respectively.3
Patient selection is a key factor in determining the surgical
outcome. Whilst previous research has examined the factors that
predict the need for surgery in AUGIB, few have studied factors that
predict outcome from surgery. Mortality after surgery for bleeding
peptic ulcer is thought to correlate with APACHE II score, with an
associatedmortality of 6%, 22% and 50% for APACHE II scores of<15,
>10 and 15 respectively.10,11 However in the current study the
equivalent in-hospital mortality rates were 8%, 11% and 11%
respectively. In the present study increasing post-endoscopy
Rockall and Blatchford scores were related to increasing in-hospital
mortality, as were Charlson and P-POSSUM scores. ASA was less
useful in this context.
The early identiﬁcation of patients that are likely to require
surgery or interventional radiological treatment is important and
hospital protocols are now commonly in place to facilitate this
process. In the present study patients were referred on average 1.5
days after admission to the surgical team according to deﬁned
hospital guidelines, with the commonest reason being continued
bleeding despite endoscopy. In the UK audit the requirement for
surgery increased with number of units transfused, Rockall score
and number of endoscopies.3 In addition it is recommended that
surgery be performed during the hours of 08:00 to 24:00 where
fesible.9 In the present study 80% of cases were performed overall
during this time, with none performed outside these hours after
1999, whichmay relate to the publication of the NCEPOD reports on
working hours.12,13
The use of routine Helicobacter pylori eradication therapy after
surgery for acute upper gastrointestinal bleeding remains contro-
versial. In most cases endoscopy will have been performed prior to
surgerywith biopsies taken.Where these demonstrate the presence
of H. pylori, eradication therapy is suggested due to a potentially
reduced rate of rebleeding.2,14 In the present study, 51% of patients
had received H. pylori eradication treatment following surgery,
however endoscopic biopsy results were not formally analysed.
The proportion of patients requiring surgery for AUGIB has
declined since the original national audit of 1993. Indeed in the 2007
UK audit, 97% of patients were managed successfully with endo-
scopic therapy alone, 1% with radiological intervention and only 2%
with surgery.3 Possible reasons for the decreasing need for surgery
include advances in endoscopic technology, the more widespread
use of proton pump inhibitors, more aggressive eradication of H.
pylori, greater awareness of the gastrointestinal side effects of non-
steroidal anti-inﬂammatory drugs and an increase in the proportion
of AUGIB due to varices. This is certainly reﬂected in the small
number of patients requiring surgery in the present study over 12
years. In addition there has been an apparent decline in the number
of cases performed by the registrar. Indeed in the UK audit 20% of
caseswereperformedbya registrarcomparedwith0% in thepresent
study after 2004. This raises training issues for both trainees and
consultants, with the potential to worsen further as a result of
a reduction in the junior doctor working time to 48 h per week.
As expertise and technology in endoscopic and radiological
techniques increases, the proportion of patients requiring surgery
is likely to fall further. Arterial embolisation by interventional
radiologists for AUGIB was ﬁrst described in 1972.15 Many case
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summary of the data made in the discussion of their own series by
Poultsides et al. who point out that many of these series include
patients who were deemed unﬁt for surgery.16 A recent retro-
spective cohort study comparing embolisation to surgery did
demonstrate more favourable rates of morbidity and mortality in
the embolisation group, even though they were on average 5 years
older and had more comorbidity than the surgery group.17
Although there is no published randomised controlled trial to
compare surgery with interventional radiology arterial embolisa-
tion, one is currently registered and recruiting patients.18
Whilst interventional radiological arterial embolisation for
AUGIB is nowa recognised treatment option for themanagement of
bleeding not controlled at endoscopy, its main limitation has been
access to appropriate services.2 Recent guidelines on standards for
providing a 24 h interventional radiology service have been issued
by the Royal College of Radiologists in an attempt to improve on the
fewer than 10% of acute trusts in the UK that can currently offer this
service.19 Since April 2009 our own radiology department now
offers such a service. Prior to this, embolisation for AUGIB had been
available on an ad hoc basis for the preceding 2 years.
If the need for surgical intervention in patients with AUGIB
continues to diminish, the future consultant workforce may become
deskilled and how a safe and effective service would be provided is
open to debate. It is not impossible to conceive that, in order to
optimiseoutcomes inpatients inwhomendoscopic therapy fails, they
should be managed jointly by appropriately trained surgeons and
interventional radiologists, in a manner similar to rotas that have
been devised to treat vascular emergencies.
5. Conclusions
The present ﬁndings compare favourably with both regional and
national standards, highlighting the high rate of morbidity and
mortality associated with surgery for this condition. The small
volume of cases requiring surgery and the reduction in registrar
operating raises training issues. This may worsen further as inter-
ventional radiology plays an increasing role in the management of
these patients.
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